drugset
drugset / Trial / NCT00610935

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

NCT00610935 ↗

Phase 3 Terminated 82 enrolled BioCryst Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the safety and effectivess of a single intramuscular injection of peramivir for the treatment of subjects with acute, uncomplicated influenza.

Timeline

Start
2008-01
Primary completion
2008-02
Completion
2008-02

Outcome

Outcome not reported

Stopped: “This study was terminated for administrative reasons.”

Drugs

EvaluationDrugModalityDoseRoute
Subject PERAMIVIR ANHYDROUS Small molecule — Intramuscular

Indications

influenza